Detailed information for compound 1552288

Basic information

Technical information
  • TDR Targets ID: 1552288
  • Name: N-cyclopropyl-1-[1-[3-(phenoxy)propanoyl]pipe ridin-4-yl]piperidine-4-carboxamide
  • MW: 399.526 | Formula: C23H33N3O3
  • H donors: 1 H acceptors: 2 LogP: 2.24 Rotable bonds: 9
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(C1CCN(CC1)C1CCN(CC1)C(=O)CCOc1ccccc1)NC1CC1
  • InChi: 1S/C23H33N3O3/c27-22(12-17-29-21-4-2-1-3-5-21)26-15-10-20(11-16-26)25-13-8-18(9-14-25)23(28)24-19-6-7-19/h1-5,18-20H,6-17H2,(H,24,28)
  • InChiKey: SOSFSGREPKUHFI-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • N-cyclopropyl-1-[1-[3-(phenoxy)propanoyl]-4-piperidyl]piperidine-4-carboxamide
  • N-cyclopropyl-1-[1-[1-oxo-3-(phenoxy)propyl]-4-piperidinyl]-4-piperidinecarboxamide
  • N-cyclopropyl-1-[1-[3-(phenoxy)propanoyl]-4-piperidyl]isonipecotamide
  • MLS000735036
  • N-cyclopropyl-1'-(3-phenoxypropanoyl)-1,4'-bipiperidine-4-carboxamide
  • SMR000317184

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens glycoprotein hormones, alpha polypeptide Starlite/ChEMBL No references
Homo sapiens polymerase (DNA directed) iota Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
No druggable targets predicted by orthology data
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Toxoplasma gondii intraflagellar transport protein 172, putative glycoprotein hormones, alpha polypeptide 116 aa 94 aa 26.6 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Mycobacterium ulcerans DNA polymerase IV 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase eta, putative 0.0023 0.5 0.5
Echinococcus multilocularis dna polymerase eta 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Echinococcus granulosus terminal deoxycytidyl transferase rev1 0.0023 0.5 0.5
Leishmania major DNA polymerase kappa, putative,DNA polymerase IV, putative 0.0023 0.5 0.5
Loa Loa (eye worm) ImpB/MucB/SamB family protein 0.0023 0.5 0.5
Schistosoma mansoni terminal deoxycytidyl transferase 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Echinococcus multilocularis dna polymerase kappa 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Echinococcus granulosus dna polymerase kappa 0.0023 0.5 0.5
Leishmania major DNA polymerase eta, putative 0.0023 0.5 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.5 0.5
Brugia malayi ImpB/MucB/SamB family protein 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Trichomonas vaginalis DNA polymerase IV / kappa, putative 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase IV, putative 0.0023 0.5 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.5 0.5
Giardia lamblia DINP protein human, muc B family 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.5 0.5
Mycobacterium tuberculosis Conserved hypothetical protein 0.0023 0.5 0.5
Schistosoma mansoni rab geranylgeranyl transferase alpha subunit 0.0023 0.5 0.5
Echinococcus granulosus dna polymerase eta 0.0023 0.5 0.5
Loa Loa (eye worm) hypothetical protein 0.0023 0.5 0.5
Entamoeba histolytica deoxycytidyl transferase, putative 0.0023 0.5 0.5
Mycobacterium ulcerans DNA polymerase IV 0.0023 0.5 0.5
Trypanosoma brucei unspecified product 0.0023 0.5 0.5
Leishmania major DNA polymerase kappa, putative 0.0023 0.5 0.5
Trichomonas vaginalis DNA polymerase eta, putative 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5
Mycobacterium tuberculosis Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) 0.0023 0.5 0.5
Trypanosoma cruzi DNA polymerase eta, putative 0.0023 0.5 0.5
Trypanosoma cruzi DNA polymerase kappa, putative 0.0023 0.5 0.5
Echinococcus multilocularis terminal deoxycytidyl transferase rev1 0.0023 0.5 0.5
Schistosoma mansoni DNA polymerase eta 0.0023 0.5 0.5
Trypanosoma brucei DNA polymerase kappa, putative 0.0023 0.5 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 1.2589 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] ChEMBL. No reference
Potency (functional) 2.8184 uM PubChem BioAssay. qHTS for Activators of Integrin-Mediated Alleviation for Muscular Dystrophy. (Class of assay: confirmatory) ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.